Drug Trial Radar · NCT06179875
An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301
Last checked: Nov 20, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
139
Actual
Start
Jan 31, 2024
Primary completion
Apr 25, 2025
Study completion Jun 23, 2025
Sponsor
- Lead sponsor
- Viridian Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 22, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The investigational drug, VRDN-001, is a monoclonal antibody that inhibits the activity of a cell surface receptor called insulin-like growth factor-1 receptor (IGF-1R). Inhibition of IGF-1R may help to reduce the inflammation and associated tissue swelling that occurs in participants with thyroid eye disease (TED). The primary objectives of this clinical trial are to provide open-label access to VRDN-001 for participants who were previously non-responders at 3 weeks post the fifth IV infusion (i.e., 15 weeks) in the VRDN-001-101 (THRIVE) and VRDN-001-301 (THRIVE-2) pivotal studies and assess the safety and efficacy of VRDN-001 in participants who were previously treated with VRDN-001 or placebo.
Conditions
- Thyroid Eye Disease
Interventions
VeligrotugDrug
Veligrotug 10 mg/kg (5 infusions of Veligrotug 10 mg/kg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proptosis Responder Rate (PRR) in the Most Proptotic Eye as Measured by ExophthalmometerTime frame: Baseline to Week 15
Locations
45 sites in 8 countries. Site status is shown where the registry gives one.
Advancing Research International, LLC
Los Angeles, California
USC Eye Institute
Los Angeles, California
Advancing Research International, LLC
Newport Beach, California
Stanford Byers Eye Institute
Palo Alto, California
Cockerham Eye Consultants, PC
San Diego, California
University of Miami Miller School of Medicine, Bascom Palmer Eye Institute
Miami, Florida
Sarasota Retina Institute
Sarasota, Florida
Vision Medical Research
Oak Lawn, Illinois
Ophthalmic Consultants of Boston
East Weymouth, Massachusetts
Kahana Oculoplastic & Orbital Surgery
Livonia, Michigan
Ophthalmic Plastic, Reconstructive, Orbital and Cosmetic Surgery
Las Vegas, Nevada
Rutgers New Jersey Medical School
Newark, New Jersey
The Center for Eye and Facial Plastic Surgery
Somerset, New Jersey
Hospital of the University of Pennsylvania Perleman Center
Philadelphia, Pennsylvania
Baylor College of Medicine
Houston, Texas
Neuro-Eye Clinical Trials
Houston, Texas
University of Vermont Medical Center
Burlington, Vermont
University of Washington Medical Center
Seattle, Washington
CHU Angers
Angers, France
Centre Hospitalier Universitaire de Montpellier Hopital Lapeyronie
Montpellier, Hérault, France
Centre Hospitalier Universitaire De Nantes G.R. Laenne
Saint-Herblain, Loire-Atlantique, France
Charite - Universitatsmedizin Berlin KoR, Campus Virchow Klinikum, Klinik tor Augenheilkunde
Berlin, Germany
Universitatsklinikum Carl Gustav Carus
Dresden, Germany
Universitatsklinikum Essen AoR - Klinik fur Augenheilkunde
Essen, Germany
University Medical Center Freiburg
Freiburg im Breisgau, Germany
Universitatmedizin Gottingen
Göttingen, Lower Saxony, Germany
Amsterdam UMC
Amsterdam, Netherlands
Uniwersytecki Szpital Kliniczny w Bialymstoku
Bialystok, Poland
Optimum Profesorskie Centrum Okulistyki
Gdansk, Poland
Centrum Medyczne Pulawska
Piaseczno, Poland
Centrum Medyczne Piasta
Wałbrzych, Piasta, Poland
Hospital Arruzafa. Servicio de Oftalmologia
Córdoba, Spain
Hospital Universitario Ramon y Cajal
Madrid, Spain
Hospital Clinico San Carlos
Madrid, Spain
Hospital Universitario Virgen de la Macarena
Seville, Spain
Hospital Universitario Miguel Servel
Zaragoza, Spain
Hacettepe Universitesi Tip Fakultesi
Ankara, Turkey (Türkiye)
Gazi University Medical Faculty Hospital
Ankara, Turkey (Türkiye)
Akdeniz University Medical Faculty Hospital
Antalya, Turkey (Türkiye)
Marmara University Faculty of Medicine
Istanbul, Turkey (Türkiye)
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.